Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

28.10.21	Pfizer And BioNTech To Provide U.S. Govt Addl 50 Million Pediatric Doses Of COVID-19 Vaccine (RTTNews)
27.10.21	CDC Recommends 4th Booster Covid Vaccine Dose For Immunocompromised People (RTTNews)
26.10.21	FDA Panel Recommends Low Doses Of Pfizer Vaccine For Kids Aged 5-11 (RTTNews)
22.10.21	Pfizer's Covid-19 Vaccine Nearly 91% Effective In Children Ages 5 To 11 (RTTNews)
21.10.21	Pfizer : Phase 3 Trial Data Shows 95.6% Efficacy In COVID-19 Vaccine Booster Dose (RTTNews)
19.10.21	Will FDA Allow 'mix And Match' Of Covid Booster Shots? (RTTNews)
15.10.21	Pfizer's Abrocitinib Receives Positive CHMP Opinion For Atopic Dermatitis Treatment (RTTNews)
14.10.21	FDA Advisory Panel Recommends Moderna's Covid-19 Booster Dose (RTTNews)
07.10.21	Pfizer Seeks Emergency Nod In U.S. For COVID-19 Vaccine In Children 5 - 11 (RTTNews)
05.10.21	EMA Committee Recommends Pfizer, Moderna COVID-19 Booster Doses (RTTNews)
29.09.21	Pfizer: Trial Data From Coadministration Of Prevnar 20 With Seasonal Flu Vaccine Positive (RTTNews)
29.09.21	FDA Expands Lilly's Erbitux Label With Braftovi For Treatment Of Metastatic Colorectal Cancer (RTTNews)
28.09.21	Pfizer, BioNTech Submit Positive Data From COVID-19 Vaccine Trial In 5 To <12 Years To FDA (RTTNews)
28.09.21	ViiV Healthcare Announces FDA's Priority Review Designation For Cabotegravir (RTTNews)
28.09.21	ViiV Enters Collaboration And License Agreement With Shionogi To Develop HIV Integrase Inhibitor (RTTNews)
27.09.21	Pfizer Begins Phase 2/3 EPIC-PEP Study To Evaluate COVID-19 Antiviral Candidate (RTTNews)
24.09.21	CDC Recommends Pfizer-BioNTech Vaccine For Booster Dose, Overrules ACIP (RTTNews)
24.09.21	Walgreens Says Pfizer COVID-19 Vaccine Booster Shots Now Available In U.S. (RTTNews)
24.09.21	CDC Advisers Recommend Pfizer Covid-19 Booster Doses For Certain Adults (RTTNews)
23.09.21	FDA Authorizes Pfizer COVID-19 Booster Shots For Older People And High-risk Workers (RTTNews)
22.09.21	Pfizer, BioNTech In Deal With U.S. To Provide 500 Mln More COVID-19 Vaccine Doses For Donation (RTTNews)
21.09.21	Nektar Collaborates With Merck KGaA, Pfizer To Evaluate NKTR-255 In Combination With Avelumab (RTTNews)
20.09.21	Pfizer Announces Positive Results From Pivotal Trial Of COVID-19 Vaccine In Children 5 - 11 Yrs (RTTNews)
18.09.21	Pfizer: Xtandi Reduces Risk Of Death By 34% In Men With Metastatic Hormone-Sensitive Prostate Cancer (RTTNews)
18.09.21	Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study (PR Newswire)
17.09.21	FDA Panel Rejects Booster Shots For Most People, But Recommends For Older Adults (RTTNews)
17.09.21	Pfizer Further Expands Recall Of Anti-smoking Drug Chantix (RTTNews)
15.09.21	Pfizer Cites 95% Efficacy In Third Vaccine Shots; FDA Staff Skeptical (RTTNews)
09.09.21	Myovant, Pfizer: FDA Accepts To Review Myfembree SNDA For Endometriosis -related Pain (RTTNews)
09.09.21	Pfizer Gets Marketing Authorization In UK For Atopic Dermatitis Drug, Cibinqo (RTTNews)
06.09.21	Pfizer Covid-19 Booster Shots Likely To Be Ready Sept. 20, But Moderna May Be Delayed : Reports (RTTNews)
02.09.21	Pfizer Starts Phase 3 Trial In Adults For Vaccine Against Respiratory Syncytial Virus - Quick Facts (RTTNews)
31.08.21	CDC Panel Backs Full Approval Of Pfizer-BioNTech COVID-19 Vaccine (RTTNews)
30.08.21	Pfizer Reports Positive Top-Line Results From Phase 3 JADE DARE Trial - Quick Facts (RTTNews)
26.08.21	Pfizer Appoints Aamir Malik As EVP And Chief Business Innovation Officer - Quick Facts (RTTNews)
26.08.21	Pfizer, BioNTech In Deal With Brazil's Eurofarma To Manufacture COVID-19 Vaccine For Latin America (RTTNews)
26.08.21	Pfizer Seeks FDA Approval For COVID-19 Vaccine Booster (RTTNews)
23.08.21	Pfizer-BioNTech's COVID-19 Vaccine Gets Full Approval From FDA (RTTNews)
23.08.21	Pfizer To Buy Trillium Therapeutics For $18.50/Shr Cash - Quick Facts (RTTNews)
18.08.21	Israel Says Third Pfizer Dose Is 86% Effective Against Covid (RTTNews)
18.08.21	Israel Says Third Pfizer Dose Is 86% Effective Against Covid (RTTNews)
17.08.21	Pfizer Expands Recall Of Anti-smoking Drug Chantix (RTTNews)
17.08.21	Pfizer, BioNTech Submit COVID-19 Booster Vaccine Data To FDA (RTTNews)
16.08.21	HLS Enters Agreement With Pfizer For Promotion Of Vascepa In Canada - Quick Facts (RTTNews)
13.08.21	FDA Oks Third Dose Of COVID-19 Vaccine For Immunocompromised Populations (RTTNews)
13.08.21	FDA Authorizes Addl. Dose Of Covid Vaccine For Immunocompromised People (RTTNews)
11.08.21	New Study Says Moderna Vaccine More Effective Against Delta Variant Than Pfizer's (RTTNews)
09.08.21	BioNTech Turns To Hefty Profit In Q2 On Covid-19 Vaccine Sale; Sees Higher Revenues Ahead; Stock Up (RTTNews)
05.08.21	Pfizer And Flynn Accused Of Illegal Pricing In U.K For Vital Anti-epilepsy Drugs (RTTNews)
04.08.21	Pfizer: Phase 2b/3 Ritlecitinib Trial Meets Primary Efficacy Endpoint In Alopecia Areata Patients (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

21.11.24		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
21.11.24		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
21.11.24		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
21.11.24		SDAX aktuell: SDAX zum Handelsende auf grünem Terrain
21.11.24		Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen
21.11.24		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
21.11.24		Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an
21.11.24		Roche-Aktie stabil: Swissmedic genehmigt subkutane Version von Ocrevus

21.11.24

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

21.11.24

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

21.11.24

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

21.11.24

SDAX aktuell: SDAX zum Handelsende auf grünem Terrain

21.11.24

Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen

21.11.24

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone